345 related articles for article (PubMed ID: 25743702)
1. Genomic landscape of paediatric adrenocortical tumours.
Pinto EM; Chen X; Easton J; Finkelstein D; Liu Z; Pounds S; Rodriguez-Galindo C; Lund TC; Mardis ER; Wilson RK; Boggs K; Yergeau D; Cheng J; Mulder HL; Manne J; Jenkins J; Mastellaro MJ; Figueiredo BC; Dyer MA; Pappo A; Zhang J; Downing JR; Ribeiro RC; Zambetti GP
Nat Commun; 2015 Mar; 6():6302. PubMed ID: 25743702
[TBL] [Abstract][Full Text] [Related]
2. Pediatric adrenocortical tumors: molecular events leading to insulin-like growth factor II gene overexpression.
Wilkin F; Gagné N; Paquette J; Oligny LL; Deal C
J Clin Endocrinol Metab; 2000 May; 85(5):2048-56. PubMed ID: 10843195
[TBL] [Abstract][Full Text] [Related]
3. SNP array profiling of childhood adrenocortical tumors reveals distinct pathways of tumorigenesis and highlights candidate driver genes.
Letouzé E; Rosati R; Komechen H; Doghman M; Marisa L; Flück C; de Krijger RR; van Noesel MM; Mas JC; Pianovski MA; Zambetti GP; Figueiredo BC; Lalli E
J Clin Endocrinol Metab; 2012 Jul; 97(7):E1284-93. PubMed ID: 22539591
[TBL] [Abstract][Full Text] [Related]
4. [Sporadic adrenocortical tumors: genetics and perspectives for the pathologist].
Tissier F
Ann Pathol; 2008 Oct; 28(5):409-16. PubMed ID: 19068395
[TBL] [Abstract][Full Text] [Related]
5. High frequency of loss of heterozygosity at 11p15 and IGF2 overexpression are not related to clinical outcome in childhood adrenocortical tumors positive for the R337H TP53 mutation.
Rosati R; Cerrato F; Doghman M; Pianovski MA; Parise GA; Custódio G; Zambetti GP; Ribeiro RC; Riccio A; Figueiredo BC; Lalli E
Cancer Genet Cytogenet; 2008 Oct; 186(1):19-24. PubMed ID: 18786438
[TBL] [Abstract][Full Text] [Related]
6. Whole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinoma.
Juhlin CC; Goh G; Healy JM; Fonseca AL; Scholl UI; Stenman A; Kunstman JW; Brown TC; Overton JD; Mane SM; Nelson-Williams C; Bäckdahl M; Suttorp AC; Haase M; Choi M; Schlessinger J; Rimm DL; Höög A; Prasad ML; Korah R; Larsson C; Lifton RP; Carling T
J Clin Endocrinol Metab; 2015 Mar; 100(3):E493-502. PubMed ID: 25490274
[TBL] [Abstract][Full Text] [Related]
7. Characterization of differential gene expression in adrenocortical tumors harboring beta-catenin (CTNNB1) mutations.
Durand J; Lampron A; Mazzuco TL; Chapman A; Bourdeau I
J Clin Endocrinol Metab; 2011 Jul; 96(7):E1206-11. PubMed ID: 21565795
[TBL] [Abstract][Full Text] [Related]
8. Identification of Clinical and Biologic Correlates Associated With Outcome in Children With Adrenocortical Tumors Without Germline TP53 Mutations: A St Jude Adrenocortical Tumor Registry and Children's Oncology Group Study.
Pinto EM; Rodriguez-Galindo C; Pounds SB; Wang L; Clay MR; Neale G; Garfinkle EAR; Lam CG; Levy CF; Pappo AS; Zambetti GP; Ribeiro RC
J Clin Oncol; 2017 Dec; 35(35):3956-3963. PubMed ID: 29058986
[TBL] [Abstract][Full Text] [Related]
9. Transcriptome analysis reveals that p53 and {beta}-catenin alterations occur in a group of aggressive adrenocortical cancers.
Ragazzon B; Libé R; Gaujoux S; Assié G; Fratticci A; Launay P; Clauser E; Bertagna X; Tissier F; de Reyniès A; Bertherat J
Cancer Res; 2010 Nov; 70(21):8276-81. PubMed ID: 20959480
[TBL] [Abstract][Full Text] [Related]
10. Somatic TP53 mutations are relatively rare among adrenocortical cancers with the frequent 17p13 loss of heterozygosity.
Libè R; Groussin L; Tissier F; Elie C; René-Corail F; Fratticci A; Jullian E; Beck-Peccoz P; Bertagna X; Gicquel C; Bertherat J
Clin Cancer Res; 2007 Feb; 13(3):844-50. PubMed ID: 17289876
[TBL] [Abstract][Full Text] [Related]
11. Mass-array screening of frequent mutations in cancers reveals RB1 alterations in aggressive adrenocortical carcinomas.
Ragazzon B; Libé R; Assié G; Tissier F; Barreau O; Houdayer C; Perlemoine K; Audebourg A; Clauser E; René-Corail F; Bertagna X; Dousset B; Bertherat J; Groussin L
Eur J Endocrinol; 2014 Mar; 170(3):385-91. PubMed ID: 24347427
[TBL] [Abstract][Full Text] [Related]
12. Clinical and molecular aspects of a pediatric metachronous adrenocortical tumor.
Lima Lde O; Lerario AM; Alencar GA; Brito LP; Almeida MQ; Domenice S; Latronico AC; Mendonca BB; Fragoso MC
Arq Bras Endocrinol Metabol; 2011 Feb; 55(1):72-7. PubMed ID: 21468523
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide analysis of recurrent copy-number alterations and copy-neutral loss of heterozygosity in head and neck squamous cell carcinoma.
Marescalco MS; Capizzi C; Condorelli DF; Barresi V
J Oral Pathol Med; 2014 Jan; 43(1):20-7. PubMed ID: 23750501
[TBL] [Abstract][Full Text] [Related]
14. Analysis of genomic alterations in sporadic adrenocortical lesions. Gain of chromosome 17 is an early event in adrenocortical tumorigenesis.
Zhao J; Speel EJ; Muletta-Feurer S; Rütimann K; Saremaslani P; Roth J; Heitz PU; Komminoth P
Am J Pathol; 1999 Oct; 155(4):1039-45. PubMed ID: 10514385
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of the APC gene is constant in adrenocortical tumors from patients with familial adenomatous polyposis but not frequent in sporadic adrenocortical cancers.
Gaujoux S; Pinson S; Gimenez-Roqueplo AP; Amar L; Ragazzon B; Launay P; Meatchi T; Libé R; Bertagna X; Audebourg A; Zucman-Rossi J; Tissier F; Bertherat J
Clin Cancer Res; 2010 Nov; 16(21):5133-41. PubMed ID: 20978149
[TBL] [Abstract][Full Text] [Related]
16. p53 Stabilization induces cell growth inhibition and affects IGF2 pathway in response to radiotherapy in adrenocortical cancer cells.
Sampaoli C; Cerquetti L; Gawhary RE; Bucci B; Amendola D; Marchese R; Misiti S; Novelli G; Toscano V; Stigliano A
PLoS One; 2012; 7(9):e45129. PubMed ID: 23028800
[TBL] [Abstract][Full Text] [Related]
17. [Childhood adrenocortical tumors: from a clinical to a molecular approach].
Antonini SR; Colli LM; Ferro L; Mermejo L; Castro Md
Arq Bras Endocrinol Metabol; 2011 Nov; 55(8):599-606. PubMed ID: 22218442
[TBL] [Abstract][Full Text] [Related]
18. Altered expression of noncanonical Wnt pathway genes in paediatric and adult adrenocortical tumours.
Mermejo LM; Leal LF; Colli LM; Fragoso MC; Latronico AC; Tone LG; Scrideli CA; Tucci S; Martinelli CE; Yunes JA; Mastellaro MJ; Seidinger AL; Brandalise SR; Moreira AC; Ramalho LN; Antonini SR; Castro M
Clin Endocrinol (Oxf); 2014 Oct; 81(4):503-10. PubMed ID: 24717047
[TBL] [Abstract][Full Text] [Related]
19. Wnt/beta-catenin and 3',5'-cyclic adenosine 5'-monophosphate/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors.
Gaujoux S; Tissier F; Groussin L; Libé R; Ragazzon B; Launay P; Audebourg A; Dousset B; Bertagna X; Bertherat J
J Clin Endocrinol Metab; 2008 Oct; 93(10):4135-40. PubMed ID: 18647815
[TBL] [Abstract][Full Text] [Related]
20. Differences in the molecular mechanisms of adrenocortical tumorigenesis between children and adults.
Faria AM; Almeida MQ
Mol Cell Endocrinol; 2012 Mar; 351(1):52-7. PubMed ID: 22019901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
